A review on recent advancements in ophthalmology devices: Currently in market and under clinical trials

Rajini Nagaraj, Divya Rani Bijukumar, Benjamin Mathew, Evan Alexander Scott, Mathew T. Mathew*

*Corresponding author for this work

Research output: Contribution to journalReview article

Abstract

The complex anatomical features of the eye and the presence of different ocular barriers has led to complications in the development of an effective treatment strategy for posterior segment diseases like diabetic retinopathy, age-related macular degeneration, retinal pigmentosa, etc., thus demanding the need for novel and innovative approaches. There are various treatment options available in the market which includes the new implants and drug delivery systems apart from the therapeutic agents which are benefiting the patients with modern improvements, enhanced formulations, targeted and long-term delivery. But they all still have numerous drawbacks which need to be addressed. This review article discusses and highlights the recent developments made in the ophthalmology which are in the market currently and under clinical trial. This review also suggests a possible alternative system that can be an effective and practical option for the treatment of posterior segment ophthalmic diseases.

Original languageEnglish (US)
Pages (from-to)334-345
Number of pages12
JournalJournal of Drug Delivery Science and Technology
Volume52
DOIs
StatePublished - Aug 1 2019

Fingerprint

Ophthalmology
Clinical Trials
Equipment and Supplies
Eye Diseases
Macular Degeneration
Diabetic Retinopathy
Therapeutics
Drug Delivery Systems

Keywords

  • Electronic retinal implants
  • Nanoparticle drug delivery systems
  • Ocular diseases
  • Ocular drug delivery
  • Ophthalmic devices
  • Ophthalmic implants

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Nagaraj, Rajini ; Bijukumar, Divya Rani ; Mathew, Benjamin ; Scott, Evan Alexander ; Mathew, Mathew T. / A review on recent advancements in ophthalmology devices : Currently in market and under clinical trials. In: Journal of Drug Delivery Science and Technology. 2019 ; Vol. 52. pp. 334-345.
@article{9b76537f21ad4cae96e0929595394e66,
title = "A review on recent advancements in ophthalmology devices: Currently in market and under clinical trials",
abstract = "The complex anatomical features of the eye and the presence of different ocular barriers has led to complications in the development of an effective treatment strategy for posterior segment diseases like diabetic retinopathy, age-related macular degeneration, retinal pigmentosa, etc., thus demanding the need for novel and innovative approaches. There are various treatment options available in the market which includes the new implants and drug delivery systems apart from the therapeutic agents which are benefiting the patients with modern improvements, enhanced formulations, targeted and long-term delivery. But they all still have numerous drawbacks which need to be addressed. This review article discusses and highlights the recent developments made in the ophthalmology which are in the market currently and under clinical trial. This review also suggests a possible alternative system that can be an effective and practical option for the treatment of posterior segment ophthalmic diseases.",
keywords = "Electronic retinal implants, Nanoparticle drug delivery systems, Ocular diseases, Ocular drug delivery, Ophthalmic devices, Ophthalmic implants",
author = "Rajini Nagaraj and Bijukumar, {Divya Rani} and Benjamin Mathew and Scott, {Evan Alexander} and Mathew, {Mathew T.}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.jddst.2019.04.038",
language = "English (US)",
volume = "52",
pages = "334--345",
journal = "Journal of Drug Delivery Science and Technology",
issn = "1773-2247",
publisher = "Editions de Sante",

}

A review on recent advancements in ophthalmology devices : Currently in market and under clinical trials. / Nagaraj, Rajini; Bijukumar, Divya Rani; Mathew, Benjamin; Scott, Evan Alexander; Mathew, Mathew T.

In: Journal of Drug Delivery Science and Technology, Vol. 52, 01.08.2019, p. 334-345.

Research output: Contribution to journalReview article

TY - JOUR

T1 - A review on recent advancements in ophthalmology devices

T2 - Currently in market and under clinical trials

AU - Nagaraj, Rajini

AU - Bijukumar, Divya Rani

AU - Mathew, Benjamin

AU - Scott, Evan Alexander

AU - Mathew, Mathew T.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - The complex anatomical features of the eye and the presence of different ocular barriers has led to complications in the development of an effective treatment strategy for posterior segment diseases like diabetic retinopathy, age-related macular degeneration, retinal pigmentosa, etc., thus demanding the need for novel and innovative approaches. There are various treatment options available in the market which includes the new implants and drug delivery systems apart from the therapeutic agents which are benefiting the patients with modern improvements, enhanced formulations, targeted and long-term delivery. But they all still have numerous drawbacks which need to be addressed. This review article discusses and highlights the recent developments made in the ophthalmology which are in the market currently and under clinical trial. This review also suggests a possible alternative system that can be an effective and practical option for the treatment of posterior segment ophthalmic diseases.

AB - The complex anatomical features of the eye and the presence of different ocular barriers has led to complications in the development of an effective treatment strategy for posterior segment diseases like diabetic retinopathy, age-related macular degeneration, retinal pigmentosa, etc., thus demanding the need for novel and innovative approaches. There are various treatment options available in the market which includes the new implants and drug delivery systems apart from the therapeutic agents which are benefiting the patients with modern improvements, enhanced formulations, targeted and long-term delivery. But they all still have numerous drawbacks which need to be addressed. This review article discusses and highlights the recent developments made in the ophthalmology which are in the market currently and under clinical trial. This review also suggests a possible alternative system that can be an effective and practical option for the treatment of posterior segment ophthalmic diseases.

KW - Electronic retinal implants

KW - Nanoparticle drug delivery systems

KW - Ocular diseases

KW - Ocular drug delivery

KW - Ophthalmic devices

KW - Ophthalmic implants

UR - http://www.scopus.com/inward/record.url?scp=85065137402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065137402&partnerID=8YFLogxK

U2 - 10.1016/j.jddst.2019.04.038

DO - 10.1016/j.jddst.2019.04.038

M3 - Review article

AN - SCOPUS:85065137402

VL - 52

SP - 334

EP - 345

JO - Journal of Drug Delivery Science and Technology

JF - Journal of Drug Delivery Science and Technology

SN - 1773-2247

ER -